With a 25bp rise to 4% widely expected, the trade sits in the MPC split, inflation forecasts, and what Bailey…
Brent Has Lost $20 in Eight Days. Here Is Which Side of the Trade to Be On.
Oil’s fastest drop of the year splits the market cleanly: energy producers absorb the pain while airlines stand to gain,…
AMD Has $11.5 Billion of Inventory Riding on 2027
Data Center revenue rose 97% in Q3. The test is whether $17B of Q4 guidance turns stock into cash.
HubSpot Reports Tonight. The Pricing Model Is the Only Number That Matters.
With HUBS down 41% year-to-date and Q3 results due after the close, Wall Street's real question is whether October's seat-to-credits…
ISM at 55.5 and $800B in Q1 Borrowing Put the 2-Year in Focus
Monday’s data raises the bar for holding steady into Friday’s payrolls.
Estée Lauder’s Margins Just Proved the Turnaround
A beat on sales and a 230-basis-point gross margin jump give patient investors the first clean confirmation that the restructuring…
Novo Nordisk Is Bleeding Profit to Win Obesity. Amgen Isn’t.
With MariTide running nine Phase 3 studies, Tuesday’s earnings may be the cheapest entry into the obesity race.
Analog Devices Reports Nov. 24. Industrial Restocking Still Waits.
With over half of ADI’s industrial subsegments still 10%+ below consumption and Q4 EPS guided to $3.71–$4.01, the cycle may…
Tesla Shareholders Hold the Only Real Veto on a SpaceX Merger
Not voting counts as a no. Here is what you would give up, and gain.
Biotech Rose 4.3% the Week Software Fell 5.9%
Friday's Gilead and Incyte gap-ups, against the Nasdaq's worst session since June, look less like a coincidence and more like…